Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trialAchim Rittmeyer, David R. Gandara, Fortunato Ciardiello et al.|The Lancet|2016Cited by 4.8k
Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational surveyCheryl Vidall, Florian Scotté, Paz Fernández‐Ortega et al.|Supportive Care in Cancer|2015Cited by 58